Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00731666 · ClinicalTrials.gov registry record · NA

Evaluation of the Coloplast Titan® IPP for Maintaining Penile Length While Treating Erectile Dysfunction (ED)

A NA study of Erectile Dysfunction, sponsored by Coloplast A/S.

Completed
Registry status
NA
Development phase
40
Enrollment target
3
Study locations

NCT00731666 is a NA study of Erectile Dysfunction that has completed, run by Coloplast A/S. The registered enrollment target is 40 participants, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (83% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00731666, a NA study of Erectile Dysfunction, has completed, sponsored by Coloplast A/S.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
3
Study locations

Study Summary

This study is designed to assess the effectiveness of the Coloplast Titan® Inflatable Penile Prosthesis (IPP) at maintaining or increasing penile length after implantation of the device. It will incorporate a modified method of cylinder sizing during implantation and a max-inflate technique after implantation.

Conditions Studied

Interventions

  • DEVICE Inflatable Penile Prosthesis

Study Locations (3)

Florida

  • James A Haley VA - Tampa

Louisiana

  • Regional Urology, LLC - Shreveport

Texas

  • University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2007-12
Est. Completion 2011-05
Phase NA

Sponsor

Coloplast A/S

21 total trials

What the Registry Record Tells You About NCT00731666

The ClinicalTrials.gov registry entry for NCT00731666 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (83% lower). The listed sponsor is Coloplast A/S, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Inflatable Penile Prosthesis is the first listed.

NCT00731666 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Louisiana, Texas.

Frequently Asked Questions

What is clinical trial NCT00731666 about?

NCT00731666 is a clinical study titled "Evaluation of the Coloplast Titan® IPP for Maintaining Penile Length While Treating Erectile Dysfunction (ED)". This study is designed to assess the effectiveness of the Coloplast Titan® Inflatable Penile Prosthesis (IPP) at maintaining or increasing penile length after implantation of the device. It will incorporate a modified method of cylinder sizing during implantation and a max-inflate technique after im...

What is the current status of trial NCT00731666?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-12. Estimated completion is 2011-05.

What conditions does trial NCT00731666 study?

This clinical trial studies the following conditions: Erectile Dysfunction.

What interventions are being tested in trial NCT00731666?

The interventions under investigation include: Inflatable Penile Prosthesis (DEVICE).

Who is sponsoring clinical trial NCT00731666?

This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00731666 being conducted?

This trial has 3 study locations across Florida, Louisiana, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Erectile Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.